In Japan, all citizens are covered under public health insurance. This universal insurance system is called the National Health Insurance, or NHI, System. It is …
Over the past decade, the pharmaceutical industry has shifted remarkably due to the changing needs of customers impacting demand for pharmaceutical products on a global …
The forthcoming step changes in medical device transparency and traceability requirements, under new European regulations, don’t just affect manufacturers. Ben Jacoby of Sensus Group explains …
On 1 January 2020, Russia will introduce a new, compulsory system for tracking pharmaceuticals from manufacturer to end user. This new legislation should be considered …
Respiratory drug development is challenging and only 3 per cent of the drugs for which a clinical trial is started end up on the market, …
Poor water solubility is an increasingly common issue in pharmaceutical development. Approximately 40% of marketed drugs and as many as 90% of active pharmaceutical ingredients …
The term rare, or orphan disease can encompass any one of more than 6000 conditions. Some, such as cystic fibrosis or Tourette’s syndrome, are well …
One of the main specificities of the paediatric population is that this is a heterogeneous population. Potential paediatric patients are neonates, newborns, infants and toddlers, …
Senescent cells were first described in the late 1950s but remained largely a curiosity until 2008 when their dark nature was revealed by Dr Judith …
We have all heard that the journey is as critical as the destination. However, in the world of clinical supplies, did you know that most …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative